BioPharm Systems enters Inc. magazine's list of fastest-growing private companies in U.S


BioPharm Systems, a leading provider of clinical trial, data, and safety solutions, today announced that it has been named to Inc. magazine's list of the fastest-growing private companies in the United States for 2010. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. BioPharm Systems was recognized for its 60 percent three-year growth rate.

"We are honored to be named among the many other prestigious companies in America," said Alex Sefanov, president and CEO of BioPharm Systems. "BioPharm has been growing at a consistent rate for many years. Our team continues to develop and provide new solutions in order to meet our clients' needs. This past year we launched a Siebel Clinical Trial Management System (CTMS) accelerator called ASCEND, and it has been generating a lot of interest due to its robust features, cost-effectiveness, and fast implementation process. We also have developed several other solutions, including Accel-Transfer, which is a tool that extracts, transforms, and loads data from one safety application into another.

BioPharm Systems, an Oracle Gold Partner specializing in Oracle Health Sciences' suite of clinical and safety applications, opened an office in the United Kingdom earlier this year, which has allowed the company to serve EMEA life sciences organizations better.

Inc. magazine has published its annual list of the fastest-growing privately held companies in the United States since 1982. Oracle, Patagonia, E*Trade, American Apparel, Zipcar, and numerous other well-known brands have been honored by the Inc. 500|5000.

Source:

BioPharm Systems, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide rewires appetite and slashes calorie intake in new obesity trial